By entering your email and pushing continue, you are agreeing to Fox News' Terms of Use and Privacy Policy, which includes our Notice of Financial Incentive.

That includes the approval of "innovative" drugs like Tryvio for high blood pressure, Neffy for severe allergic reactions and Dupixent for chronic obstructive pulmonary disease (COPD), which all gained FDA approval this year.

These medications are "slated to make a big clinical impact for those who need them," according to GoodRx, a California-based digital health care platform.

HOW ARE PRESCRIPTION DRUGS NAMED? A DRUG DEVELOPMENT EXPERT SHARES THE PROCESS

Earlier this month, GoodRx released a list of the 19 most influential drug and vaccine approvals of 2024, some newly designed to treat certain conditions and other existing medications that were approved for additional uses.

Here is the list in order of FDA approval date.

1. Dupixent - Additional use: Eosinophilic esophagitis (an allergic condition that causes inflammation of the esophagus)

7 OF GOOGLE'S MOST-SEARCHED HEALTH QUESTIONS IN 2024 WITH EXPERT RESPONSES

5 MAJOR ALZHEIMER'S DISCOVERIES SCIENTISTS MADE IN 2024

13. Voquezna - Additional use: Heartburn from non-erosive GERD (gastroesophageal reflux disease)

14. Zunveyl - New medication: Alzheimer's disease

15. Yorvipath - New medication: Hypoparathyroidism (low levels of the parathyroid hormone)

In a disclaimer, GoodRx noted that the list was created by prioritizing "first-in-class medications and vaccines that are expected to have a significant impact on human health."

"This was defined as either the number of lives touched or the expected degree of impact for future medication recipients," the company wrote.

"We also prioritized medications with effectiveness or safety data that represent a notable advantage over other medications recommended by clinical treatment guidelines or mainstay medical organizations."

CLICK HERE TO GET THE FOX NEWS APP

Fox News Digital reached out to GoodRx for comment.